Antibody LNP Conjugation Kit

The success of in vivo CAR therapy hinges on the precise delivery of CAR-encoding mRNA to target immune cells. Synthgene Biotech, a pioneer with a strong background in chemical biology, offers a one-stop solution for controllable, efficient, and highly active HiSynth® antibody-LNP conjugation, completely resolving the core challenges of traditional methods such as poor targeting, off-target effects, loss of activity, and process instability.

Ordering information

Catalog #	Product / Service	Specifications / Deliverables
10116	Antibody LNP Conjugation Kit	5 Rxn (200ug Ab-LNP/Rxn)
—	Antibody-LNP conjugation and encapsulation service Service	Ab-LNP and quality control report

Highly Efficient Conjugation, Maximum Activity

Multiple Conjugation Tools: The core team is proficient in various antibody conjugation methods and has published numerous related articles.
Mature Conjugation Platform: Stable process, high conjugation efficiency, and minimal batch-to-batch variation ensure data reliability.
Complete Activity Guarantee: Ensures that the conjugated antibody retains its native conformation and biological function, achieving “once loaded, it can still run.”

Flexible Collaboration, Accelerated Industrialization

Flexible Collaboration Models: Using our antibody-LNP conjugation kit allows you to independently explore the conjugation process.
Industrialization Implementation: The conjugation technology platform has achieved process scale-up.

Technology Platform	Traditional	HiSynth®
Antibody activity	Aggregation and inactivation	Retains native conformation
Process stability	Uncontrollable, unstable	Stable, high efficiency
Impurity control	Many by-products	Good specificity, controllable
Safety	Potential immunogenic risk	High biocompatibility

Request a quotation

Tell us the target, the scale and the timeline you need. A scientist replies with pricing and a recommended route.

Contact sales